Synageva BioPharma (GEVA)

Add to Watchlists
Create an Alert
84.09 +6.24  +8.02% NASDAQ Apr 22, 8:00PM BATS Real time Currency in USD

Synageva BioPharma Current Ratio (Quarterly):

29.94 for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Synageva BioPharma Current Ratio (Quarterly) Chart

Export Data
Save Image

Synageva BioPharma Historical Current Ratio (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 29.94
Sept. 30, 2013 32.78
June 30, 2013 23.53
March 31, 2013 30.03
Dec. 31, 2012 17.21
Sept. 30, 2012 17.29
June 30, 2012 8.346
March 31, 2012 8.986
Dec. 31, 2011 7.828
Sept. 30, 2011 43.60
June 30, 2011 38.76
March 31, 2011 54.89
Dec. 31, 2010 10.12
Sept. 30, 2010 39.42
June 30, 2010 30.32
March 31, 2010 12.60
Dec. 31, 2009 8.513
Sept. 30, 2009 24.34
June 30, 2009 20.16
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Current Ratio

The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. The ratio illustrates a company's ability to remain solvent.

A current ratio of one means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning current assets twice as large as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.

Other similar solvency ratios include :
Cash Ratio - Measures the amount of cash that can be used to pay liabilities (most strict)
Quick Ratio - Measures the amount of cash, short term equivalents, and accounts receivables that can be used to pay liabilities (more lenient than cash ratio, but stricter than current ratio)
Learn More

Get data for
Advertisement

GEVA Current Ratio (Quarterly) Benchmarks

Companies
Alexion Pharmaceuticals 3.755
Actelion 2.078
Gilead Sciences 1.150

GEVA Current Ratio (Quarterly) Range, Past 5 Years

Minimum 7.828 Dec 2011
Maximum 54.89 Mar 2011
Average 24.14
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.